Arcticzymes Technologies ASA

Price Chart

Risk-Adjusted Performance

Also Listed On

Arcticzymes Technologies ASA (AZT) Price Performance

Arcticzymes Technologies ASA (AZT) trades on Oslo Stock Exchange in NOK. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at NOK20.00, up 3.63% from the previous close.

Over the past year, AZT has traded between a low of NOK15.10 and a high of NOK30.90. The stock has gained 13.6% over this period. It is currently 35.3% below its 52-week high.

Arcticzymes Technologies ASA has a market capitalization of $1.02B, with a price-to-earnings ratio of 104.74.

About Arcticzymes Technologies ASA

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools, such as research and diagnostics, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Compare Arcticzymes Technologies ASA

Side-by-side comparison against top Healthcare peers.